← Return to New, Small, Cheap, MRI, could better test for recurrence

Discussion
Comment receiving replies
Profile picture for jardinera25 @jardinera25

@lifetraveler and @coley,
I went ahead and researched online to see if I could find more on this study, and there was much more specific information! This looks like a game changer in finding the right treatment for those with bone metastasis, much more quickly.
"The study’s lead investigator, Jennifer M. Specht, MD, a medical oncologist at the University of Washington and Fred Hutch Cancer Center, presented the results of the FEATURE trial (EA1183, NCT04316117) at the 2025 San Antonio Breast Cancer Symposium. Heather A. Jacene, MD, a nuclear medicine physician from Brigham and Women’s Hospital and Dana-Farber Cancer Institute, co-led the trial with Dr. Specht." It also said "This multi-center trial involved investigators and patients at 35 hospitals and cancer centers across the United States and in Ireland. It received support from the National Cancer Institute..." So it's not just at my cancer center.
https://ecog-acrin.org/press-release-an-ecog-acrin-imaging-study-solves-a-long-standing-gap-in-metastatic-breast-cancer-research-and-care-accurately-measuring-treatment-response-in-patients-with-bone-metastases/
Looks like you have to highlight, copy & paste onto internet search bar to read the article.

Jump to this post


Replies to "@lifetraveler and @coley, I went ahead and researched online to see if I could find more..."

Hi!@jardinera25

Thank you so much for posting the link to this article!

This certainly is an exciting news for predicting treatment benefits in patients with highly (HR+) metastatic breast cancer that have spreaded primarily or exclusively to the bones. Let's hope they'll extend the research to benefit all cancer patients in the near future!

Better journey ahead, my friends!